Voglibose Regulates the Secretion of GLP-1 Accompanied by Amelioration of Ileal Inflammatory Damage and Endoplasmic Reticulum Stress in Diabetic KKAy Mice
Voglibose is an α-glycosidase inhibitor that improves postprandial hyperglycemia and increases glucagon-like peptide-1 (GLP-1) secretion in patients with type 2 diabetes. Recently, there has been increasing interest in the anti-inflammatory effects of voglibose on the intestine, but the underlying m...
Main Authors: | Yaxin Fu, Wenming Ji, Quan Liu, Lin Zhang, Caina Li, Yi Huan, Lei Lei, Xuefeng Gao, Leilei Chen, Cunyu Feng, Liran Lei, Jiayu Zhai, Pingping Li, Hui Cao, Shuainan Liu, Zhufang Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/24/15938 |
Similar Items
Similar Items
-
Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice
by: Quan Liu, et al.
Published: (2021-04-01) -
Role of Voglibose in the Treatment of Prediabetes in Indian Population: A Cross-Speciality Survey
by: Pavitra Raj Dewda, et al.
Published: (2013-10-01) -
New Therapeutic Possibilities of Type 2 Diabetes Mellitus Management: Experience of Voglibose Application
by: V.I. Pankiv
Published: (2014-09-01) -
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial
by: Tae Jung Oh, et al.
Published: (2019-06-01) -
Effective Therapy Using Voglibose for Nonalcoholic Steatohepatitis in a Patient with Insufficient Dietary and Exercise Therapy: Exploring Other Treatment Possibilities
by: Kazuki Nagai, et al.
Published: (2011-06-01)